A virus-host cell-binding assay was developed and used to investigate specific binding between group A porcine rotavirus and MA-104 cells or porcine enterocytes. A variety of glycoconjugates and cellular components were screened for their ability to block rotavirus binding to cells. During these experiments a crude ganglioside mixture was observed to specifically block rotavirus binding. On the basis of these results, enterocytes were harvested from susceptible piglets and a polar lipid fraction was isolated by solvent extraction and partitioning. Throughout subsequent purification of this fraction by Sephadex partition, ion-exchange, silicic acid, and thin-layer chromatography, blocking activity behaved as a monosialoganglioside (GMX) that displayed a thin-layer chromatographic mobility between those of GM2 and GM3. The blocking activity of GMX was inhibited by treatment with neuraminidase and ceramide glycanase but not by treatment with protease or heat (100°C). Further purification of GMX by high-pressure liquid chromatography resulted in the resolution of two monosialogangliosides, GMX and a band which comigrated with GM1 on thin-layer chromatography. These data suggest that a cell surface monosialoganglioside or family of monosialogangliosides may function as an in vivo relevant receptor for group A porcine rotavirus and that sialic acid is a required epitope for virus-binding activity.
Group A rotaviruses are among the most important agents associated with severe diarrhea in the young of humans and other animals (6, 8, 9, 18, 24, 54) . They are a major cause of morbidity in infants and young children in developed countries and of morbidity and mortality in those in developing countries. It is estimated that more than one million children die each year of human rotavirus infections (3, 5) . Rotavirus infections are also of prime agricultural importance since they frequently cause serious neonatal diarrheal diseases of many animal species, most importantly neonatal and postweaning pigs and calves. Morbidity due to rotavirus infections in these species often reaches 80%, and mortality can be as high as 60% (6) .
Despite considerable research efforts in many laboratories, rotavirus diarrhea continues to be a serious and costly disease in both animals and humans and has recently become important in causing significant illness in immunocompromised people (38, 62) and debilitated neonates (35) . Despite extensive efforts including the use of reassortants, attenuated live strains, and vector expression of VP4 and/or VP7, a vaccine which is protective across all rotavirus serotypes is not available. To establish a firm scientific basis for the ultimate prevention and control of rotavirus disease, a greater understanding of the molecular mechanisms of rotavirus host cell interaction is required.
The earliest requisite step for productive viral infection is recognition and binding to villous tip enterocytes. The tissue and cell type specific tropisms displayed by rotaviruses is consistent with the hypothesis that a specific host cell surface receptor(s) mediates recognition. Recent reports (2, 21, 45, 47, 52, 60) provide strong evidence to support the existence of specific rotavirus receptors. In fact, all of these studies implicate glycoconjugates as the putative receptors. It is uncertain, however, which glycoconjugate functions as the actual receptor in vivo for a given rotavirus serotype. Some of this confusion may be due to the use of a host animal model or cell type that is not homologous to the rotavirus serotype being studied. The type of assay used to measure the virus-host cell interaction may also influence the type of receptor detected.
We have developed a whole-cell, virus-binding assay to directly test enterocyte extracts for their ability to compete for specific rotavirus binding to enterocytes or MA-104 cells in suspension. We describe here the use of this assay to identify and partially purify a porcine enterocyte ganglioside that may function as an in vivo relevant cell surface receptor for the homologous group A porcine rotavirus serotype.
(The work by M. D. Rolsma was conducted in partial fulfillment of the requirements for a Ph.D. from the University of Illinois, Urbana.) plates were E. Merck Kieselgel 60 plates without a fluorescent indicator (VWR Scientific).
Virus propagation and purification. Roller bottles (Corning) containing a nearly confluent monolayer of MA-104 (embryonic African green monkey kidney) cells (M. A. Bioproducts) grown in Eagle's minimal essential medium (MEM; GIBCO) with 10% added calf serum (GIBCO; pH 7.3) were rinsed with MEM (without added serum; pH 7.3) and incubated for 3 h at 37°C in the same serum-free medium. Group A porcine rotavirus (OSU strain) was pretreated for 30 min at 37°C with 10 ,ug of crystallized trypsin per ml. The cells were incubated with rotavirus at a multiplicity of infection of 2 to 5 PFU per cell for 90 min at 37°C. The viral inoculum was aspirated, and the cells were rinsed once with MEM. The roller bottles were then incubated with MEM (15 ml per roller bottle, without added serum) containing 10 jLg of soybean trypsin inhibitor per ml at 37°C until more than 75% of the cell monolayer was destroyed (generally less than 24 h). Roller bottles were freeze-thawed after addition of 100 ,ug of aprotinin (21) . Tissue culture fluid was extracted with equal volumes of trichlorotrifluoroethane in a Dounce tissue grinder and centrifuged in 50-ml polypropylene centrifuge tubes (Corning) at 1,750 x g for 10 min. The solvent was reextracted twice with equal volumes of MEM. The aqueous phases were combined and clarified by centrifugation in an SW28 rotor (Beckman) at 9,000 rpm for 30 min. Virus was then pelleted through a 20% sucrose cushion (with 100 mM CaCl2) in an SW28 rotor at 26,000 rpm for 2 h. The viral pellet was resuspended in virus buffer (50 mM Tris, 20 mM NaCl, 100 mM CaCl2 [pH 7.5]) containing sufficient CsCI2 (GIBCO-BRL) to achieve a homogeneous density of 1.37 g/cm3 and centrifuged for 30 h at 35,000 rpm in an SW55 rotor (Beckman). Light-scattering bands located at densities of 1.36 and 1.38 g/cm3, which corresponded to double-shelled (ds) and single-shelled (ss) virus particles, respectively, were removed and rebanded on individual CsCl2 gradients as described above.
The individual virus bands were collected and dialyzed against virus buffer by using a continuous-flow microdialysis chamber (Bethesda Research Laboratories). The purity of virus bands was estimated by using negative-staining (ammonium molybdate) electron microscopy by direct count of the number of ds and ss virus particles present in a total of 100 particles. Electron-microscopic determination of the particle concentration was performed by comparing particle numbers with dilutions of 102-nm polystyrene beads (Seradyn) at known concentrations (27) (28) . Preparative TLC was performed under the same conditions as for HPTLC except that the sample (a total of 75 to 100 plA per plate) was spotted in 0.5-cm lanes (separated by 0.5-cm blank lanes) across the entire width of the plate. After development, the first and last lanes of the plate, which were separated from the adjacent lanes by 1.5 cm to facilitate scoring, were cut and sprayed with resorcinol. These lanes were used as guides for dividing the unstained lanes into horizontal bands that extended across the entire width of the plate. Unstained bands were scraped from the plate, and the silica was exhaustively eluted with chloroform-methanol-water (30:60:20) . Silica fines were removed by centrifugation and filtration. Following evaporation and resuspension in a volume of solvent equivalent to the original applied volume, appropriate aliquots were tested for inhibitory activity in the blocking assay and were rechromatographed on HPTLC plates.
HPLC of gangliosides. HPLC of gangliosides was performed by a modification of a previously described method (14) . A Perkin-Elmer Series 3 dual-pump HPLC apparatus was used to equilibrate a Shandon Hypersil column (5-,im-diameter silica; 4.6 by 250 mm) with chloroform-methanol-water (65:25: 3). Pooled latrobead fractions were dissolved in equilibrating solvent. After injection of 100-,ul aliquots, the flow rate was continued at 1 ml/min for 30 min. A linear gradient of chloroform-methanol-water which varied from 65:25:3 to 60: 35:8 was then run at a rate of 1 ml/min for 60 min. Fractions (4 ml) were collected, evaporated by a nitrogen stream, and redissolved in 100 plA of chloroform-methanol-water (55:45:10 (Fig. 2) .
Inhibition of virus binding to MA-104 cells or enterocytes (data not shown) was dependent on the concentration of mixed brain ganglioside added (Fig. 3) . As little as 3 jig of the ganglioside sample inhibited binding by 80%, and detectable inhibition could be seen with as little as 0.5 pig. Inhibitory activity was resistant to pretreatment with trypsin or heat but was sensitive (50 to 80% inhibition) to periodate oxidation, digestion with neuraminidase, and digestion with ceramide glycanase (data not shown). None of the neoglycoproteins (46) containing either nonreducing terminal Man, GlcNAc, GIc, or Gal residues common to most glycoproteins with simple or complex oligosaccharides had any effect on virus binding. Similarly, other polyanionic glycoconjugates such as glycosaminoglycans, sialylated glycoproteins, or polysialylated C polysaccharide (25) and the colominic acid group failed to inhibit rotavirus binding. The marked specificity of inhibition displayed by the ganglioside fraction suggested that sialylated glycolipids, specifically gangliosides, might serve as a putative rotavirus receptor. Rotavirus binding to MA-104 cells and porcine enterocytes is inhibited by standard monosialogangliosides GM2 and GM3. We also tested standard, commercially available gangliosides of known oligosaccharide structure for their ability to inhibit virus binding. Of all the gangliosides tested, GM2 and GM3 were the most active and had comparable inhibitory activity when tested at either 1 or 10 ,ug/10 RI (50 ng) of virus (Table 2) . GM1, the disialogangliosides GDla and GD1b, and the trisialoganglioside GTIb showed almost no inhibitory activity when assayed at I ,ug. When assayed at 10 pLg, GM1 and GDla inhibited virus binding to about the same degree, whereas GDlb and GTlb inhibited it to a lesser extent. Interestingly, the asialo derivatives of GM1 (GA1), which have been shown to specifically bind the SA-11 strain of rotavirus (11), GM2 (GA2), and up to 50 ,g of soluble sialyllactose (data not shown) failed to inhibit binding. In other studies (47), GM1 has been reported to bind SA-11. Although GM1 displayed some activity in our system, it was the least active of all the monosialogangliosides tested. The same ganglioside specificity was seen when enterocytes were used instead of MA-104 cells. Our data indicated that sialic acid is a component of the binding epitope and that inhibitory activity, as measured in the blocking assay, is sensitive to minor changes in the oligosaccharide structure of gangliosides. To find a naturally occurring molecule with similar specificity, porcine en- terocyte gangliosides were isolated and their ability to inhibit virus binding was measured.
Isolation of a ganglioside fraction from porcine intestine: lipid extraction and solvent partitioning. Intestines harvested from 4-week-old pigs were lipid extracted and a crude ganglioside fraction was isolated as described in Materials and Methods. Inhibitory activity was recovered in the aqueous phase following chloroform-methanol-water solvent partitioning of the initial lipid extract. Sephadex G-25 chromatography, designed to separate the bulk of neutral lipids, free fatty acids, and glycolipids (fraction 1), bile salts and nonpolar amino acids (fraction 3), and other salts, amino acids, and sugars (fraction 4) from gangliosides (20) (Fig. 4A) displayed activity (Fig. 4B, FXN 12) .
GMX activity is neuraminidase sensitive. The inhibitory activity of the partially purified ganglioside recovered from preparative TLC (Fig. 4A, lane FXN 12 itory activity ( Table 3 ). The partial rather than complete reduction in inhibitory activity of GMX by ceramide glycanase and to a lesser extent by neuraminidase may be due to several factors. These include the relative impurity of the fraction, the possible presence of sialic acid glycosidic linkages in GMX that are relatively resistant to C. perfringens neuraminidase, and the wide variation in ceramide glycanase cleavage rates, which is dependent on ganglioside structure (36) . Although fraction 12 is more highly purified than the DEAE II fraction, it still contained nonganglioside contaminating material. Gangliosides, especially in low concentration and in the presence of contaminants, can show aberrant or inconsistent chromatographic mobility during TLC. Apparent single ganglioside bands can often be separated into multiple gangliosides or display different chromatographic mobility once traces of contaminating material (especially phospholipids and hydrophobic polypeptides) are removed. For these reasons further purification of DEAE fraction II by HPLC was attempted.
HPLC purification of enterocyte gangliosides. DEAE fraction II prepared as above from pooled intestinal mucosa of a different group of piglets was chromatographed on an HPLC silica (Hypersil) column, and aliquots of eluted fractions were assayed for inhibitory activity and chromatographed on thinlayer plates. These procedures resulted in the separation and visualization of two active, resorcinol-positive bands (Fig. 5) . One of these gangliosides had identical mobility to the major component of GMX. The other, more polar ganglioside comigrated with standard GMI (Fig. 5) . These data suggest that more than one enterocyte monosialoganglioside may support rotavirus-host cell recognition. Individual variation in enterocyte ganglioside composition may also exist. Interestingly, when standard gangliosides used as references during TLC were assayed for inhibitory activity, both GM3 and GM2 displayed almost equal activity whereas GM1 was relatively inactive (Fig. 4B) . Thus, even though the more polar enterocyte ganglioside displayed a TLC mobility similar to that of standard bovine GM1, its blocking activity suggests that it is unlikely that this ganglioside is structurally identical to GM1 isolated from bovine brain.
Gangliosides restore viral binding following neuraminidase treatment of MA-104 cells. Neuraminidase treatment of MA-104 cells prior to their use in the binding assay inhibited binding by 84% (Table 4 ). To further demonstrate the importance of sialic acid in rotaviral binding, we exploited the ability of gangliosides to self-insert into cellular membranes. Incubation of neuraminidase-treated cells with variable quantities of mixed gangliosides resulted in a dose-dependent recovery of the ability of MA-104 cells to bind ds particles. These experi- ments provide additional evidence that sialic acid is a necessary epitope for specific binding of porcine group A rotavirus.
DISCUSSION
Despite decades of research on rotavirus-induced diseases in swine and other mammals, an efficacious vaccine is not available and treatment is largely supportive. Such therapy, designed to combat the electrolyte loss and dehydration which accompany virus-induced destruction of villous enterocytes, does not directly address the pathophysiology of infection. Since infection of enterocytes is necessarily preceded by recognition of and attachment to the cell surface by rotavirus, it follows that an understanding of the biology of this interaction is crucial for the development of rational prophylactic or therapeutic techniques. Our approach has been to develop systems capable of identification, purification, and biochemical characterization of the molecules on the surface of the enterocytes which are responsible for the ability of rotaviruses to recognize, attach to, and infect enterocytes.
The kinetics of rotavirus binding to whole MA-104 cells as well as isolated porcine enterocytes in suspension demon- (45) , using a murine rotavirus model, presented strong evidence indicating that simian rotavirus (SA-1 1) specifically recognizes neutral glycolipids, particularly asialo-GM1 (GA1) and asialo-GM2 (GA2). These authors suggested that GAl is not the in vivo receptor since high levels of endogenous GAl correlated with resistance to spontaneous rotavirus disease.
Superti and Donelli (47) indicated that gangliosides, specifically GM1, serve as putative simian rotavirus (SA-11) receptors. These authors suggested that GM1 may be the physiologically relevant receptor for SA-11. GA1, GM2, and GM3 were not evaluated in their assay systems. In addition, GM1 was not directly tested for its ability to block virus binding to enterocytes.
Bass et al. (2) A key characteristic of rotavirus-host cell recognition may be the multivalent binding of virus particles to optimally spaced low-affinity cell surface carbohydrate epitopes, effectively resulting in an overall high-affinity interaction. The importance of multivalency in viral binding is exemplified by the demonstration that the multimeric hemagglutinin of influenza virus binds most avidly to multiple optimally spaced sialic acid residues. Oligosaccharides derived from equine a2-macroglobulin (a high-affinity glycoprotein receptor for influenza virus hemagglutinin) and human ox2-macroglobulin (a low-affinity glycoprotein receptor for influenza virus hemagglutinin) each bind with equal, relatively low affinity. Elegant studies by Glick et al. (13) , showed that the spatial configuration of sialic acid residues is the critical determinant for optimal ligand binding to the hemagglutinin. Multivalency has also been observed in other protein-carbohydrate-binding systems (15, 22, 57 
